Haichang Biotech Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is BUPIVACAINE, with a corresponding US DMF Number 41135.
Remarkably, this DMF maintains an Active status since its submission on January 26, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 07, 2025, and payment made on February 21, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II